• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Annovis Bio upgraded by Maxim Group with a new price target

    10/25/24 7:56:01 AM ET
    $ANVS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ANVS alert in real time by email
    Maxim Group upgraded Annovis Bio from Hold to Buy and set a new price target of $25.00
    Get the next $ANVS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ANVS

    DatePrice TargetRatingAnalyst
    2/10/2025Buy → Hold
    D. Boral Capital
    10/25/2024$25.00Hold → Buy
    Maxim Group
    12/29/2023$36.00Buy
    Canaccord Genuity
    7/7/2021$45.00 → $150.00Buy
    Maxim Group
    More analyst ratings

    $ANVS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Annovis Bio downgraded by D. Boral Capital

      D. Boral Capital downgraded Annovis Bio from Buy to Hold

      2/10/25 8:18:59 AM ET
      $ANVS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Annovis Bio upgraded by Maxim Group with a new price target

      Maxim Group upgraded Annovis Bio from Hold to Buy and set a new price target of $25.00

      10/25/24 7:56:01 AM ET
      $ANVS
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Canaccord Genuity initiated coverage on Annovis Bio with a new price target

      Canaccord Genuity initiated coverage of Annovis Bio with a rating of Buy and set a new price target of $36.00

      12/29/23 7:03:31 AM ET
      $ANVS
      Biotechnology: Pharmaceutical Preparations
      Health Care